{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T11:36:15Z","timestamp":1774524975842,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T00:00:00Z","timestamp":1594252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T00:00:00Z","timestamp":1594252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The seroprevalence of human Parvovirus B19 (PVB19) is 70\u201385% in adults worldwide. PVB19 is the etiologic agent of the fifth disease, is a cause of aplastic anemia, and can be associated with kidney injury. We aimed to describe the cases of 4 patients with kidney injury related to PVB19 primary infection, and to evaluate the seroprevalence of PVB19 and the incidence of PVB19 primary infection in patients undergoing a native kidney biopsy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Cases of PVB19 infection with kidney injury were reviewed from the archives of the department of Nephrology. A systematic screening of anti-PVB19 IgG and IgM antibodies and viral DNA was performed in sera from 100 consecutive patients with a kidney biopsy in 2017\u20132018.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The 4 patients with PVB19 infection-associated kidney disease displayed: one lupus-like glomerulonephritis (GN) without lupus auto-antibodies, one minimal change disease with tubular necrosis, one secondary hemolytic and uremic syndrome and one membrano-proliferative GN. In the 100 patients biopsied, 67 had elevated anti-PVB19 IgG, among whom 8 had elevated IgM, without circulating viral DNA, without any particular renal pathological pattern. One additional patient showed a seroconversion at the time of kidney biopsy, which revealed a class V lupus nephritis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>PVB19 primary infection can be associated with different kidney diseases. The seroprevalence of PVB19 among patients with a kidney biopsy is similar to the overall population, and primary infection is rarely documented (1%) after systematic screening. Whether PV19 is nephrotoxic, or triggers renal endothelial injury and immune activation, remains to be elucidated.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12882-020-01911-9","type":"journal-article","created":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T08:05:10Z","timestamp":1594281910000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Parvovirus B19 infection and kidney injury: report of 4 cases and analysis of immunization and viremia in an adult cohort of 100 patients undergoing a kidney biopsy"],"prefix":"10.1186","volume":"21","author":[{"given":"Ma\u00eblis","family":"Kauffmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micka\u00ebl","family":"Bobot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Torrents","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yannick","family":"Knefati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Moranne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"Burtey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Zandotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9315-1577","authenticated-orcid":false,"given":"No\u00e9mie","family":"Jourde-Chiche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,9]]},"reference":[{"issue":"11","key":"1911_CR1","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1017\/S0950268807009958","volume":"136","author":"C R\u00f6hrer","year":"2008","unstructured":"R\u00f6hrer C, G\u00e4rtner B, Sauerbrei A, B\u00f6hm S, Hottentr\u00e4ger B, Raab U, et al. Seroprevalence of parvovirus B19 in the German population. Epidemiol Infect. 2008;136(11):1564\u201375.","journal-title":"Epidemiol Infect"},{"issue":"6","key":"1911_CR2","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1503\/cmaj.045293","volume":"172","author":"E Weir","year":"2005","unstructured":"Weir E. Parvovirus B19 infection: fifth disease and more. CMAJ Can Med Assoc J J Assoc Medicale Can. 2005;172(6):743.","journal-title":"CMAJ Can Med Assoc J J Assoc Medicale Can"},{"issue":"1","key":"1911_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.nephro.2011.06.001","volume":"8","author":"A Brodin-Sartorius","year":"2012","unstructured":"Brodin-Sartorius A, Mekki Y, Bloquel B, Rabant M, Legendre C. Parvovirus B19 infection after kidney transplantation. Nephrol Ther. 2012;8(1):5\u201312.","journal-title":"Nephrol Ther"},{"issue":"Suppl 1","key":"1911_CR4","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.2215\/CJN.01060307","volume":"2","author":"M Waldman","year":"2007","unstructured":"Waldman M, Kopp JB. Parvovirus B19 and the kidney. Clin J Am Soc Nephrol CJASN. 2007;2(Suppl 1):S47\u201356.","journal-title":"Clin J Am Soc Nephrol CJASN"},{"issue":"1","key":"1911_CR5","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12882-016-0330-7","volume":"17","author":"W Besse","year":"2016","unstructured":"Besse W, Mansour S, Jatwani K, Nast CC, Brewster UC. Collapsing glomerulopathy in a young woman with APOL1 risk alleles following acute parvovirus B19 infection: a case report investigation. BMC Nephrol. 2016;17(1):125.","journal-title":"BMC Nephrol"},{"key":"1911_CR6","doi-asserted-by":"crossref","unstructured":"Moudgil A, Nast CC, Bagga A, Wei L, Nurmamet A, Cohen AH, et al. Association of parvovirus B19 infection with idiopathic collapsing glomerulopathy. Kidney Int. 2001;59(6):2126\u201333.","DOI":"10.1046\/j.1523-1755.2001.00727.x"},{"issue":"6","key":"1911_CR7","first-page":"1227","volume":"29","author":"CM Magro","year":"2002","unstructured":"Magro CM, Crowson AN, Dawood M, Nuovo GJ. Parvoviral infection of endothelial cells and its possible role in vasculitis and autoimmune diseases. J Rheumatol. 2002;29(6):1227\u201335.","journal-title":"J Rheumatol"},{"issue":"6","key":"1911_CR8","doi-asserted-by":"publisher","first-page":"e31.1","DOI":"10.1016\/S0272-6386(00)70070-9","volume":"35","author":"T Nakazawa","year":"2000","unstructured":"Nakazawa T, Tomosugi N, Sakamoto K, Asaka M, Yuri T, Ishikawa I, et al. Acute glomerulonephritis after human parvovirus B19 infection. Am J Kidney Dis. 2000;35(6):e31.1\u20138.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"1911_CR9","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1128\/CMR.15.3.485-505.2002","volume":"15","author":"ED Heegaard","year":"2002","unstructured":"Heegaard ED, Brown KE. Human parvovirus B19. Clin Microbiol Rev. 2002;15(3):485\u2013505.","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"1911_CR10","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0166-0934(00)00292-5","volume":"92","author":"C Aberham","year":"2001","unstructured":"Aberham C, Pendl C, Gross P, Zerlauth G, Gessner M. A quantitative, internally controlled real-time PCR assay for the detection of parvovirus B19 DNA. J Virol Methods. 2001;92(2):183\u201391.","journal-title":"J Virol Methods"},{"issue":"5","key":"1911_CR11","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0369-8114(02)00307-3","volume":"50","author":"M S\u00f6derlund-Venermo","year":"2002","unstructured":"S\u00f6derlund-Venermo M, Hokynar K, Nieminen J, Rautakorpi H, Hedman K. Persistence of human parvovirus B19 in human tissues. Pathol Biol (Paris). 2002;50(5):307\u201316.","journal-title":"Pathol Biol (Paris)"},{"issue":"2","key":"1911_CR12","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1099\/00222615-25-2-151","volume":"25","author":"BJ Cohen","year":"1988","unstructured":"Cohen BJ, Buckley MM. The prevalence of antibody to human parvovirus B19 in England and Wales. J Med Microbiol. 1988;25(2):151\u20133.","journal-title":"J Med Microbiol"},{"issue":"8","key":"1911_CR13","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1017\/S0950268807007856","volume":"135","author":"AJ Vyse","year":"2007","unstructured":"Vyse AJ, Andrews NJ, Hesketh LM, Pebody R. The burden of parvovirus B19 infection in women of childbearing age in England and Wales. Epidemiol Infect. 2007;135(8):1354\u201362.","journal-title":"Epidemiol Infect"},{"issue":"3","key":"1911_CR14","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1017\/S0950268899003817","volume":"124","author":"HA Kelly","year":"2000","unstructured":"Kelly HA, Siebert D, Hammond R, Leydon J, Kiely P, Maskill W. The age-specific prevalence of human parvovirus immunity in Victoria, Australia compared with other parts of the world. Epidemiol Infect. 2000;124(3):449\u201357.","journal-title":"Epidemiol Infect"},{"issue":"5","key":"1911_CR15","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.revmed.2013.04.015","volume":"35","author":"D Parra","year":"2014","unstructured":"Parra D, Mekki Y, Durieu I, Broussolle C, S\u00e8ve P. Clinical and biological manifestations in primary parvovirus B19 infection in immunocompetent adult: a retrospective study of 26 cases. Rev Med Interne. 2014;35(5):289\u201396.","journal-title":"Rev Med Interne"},{"issue":"2","key":"1911_CR16","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/jmv.1890350207","volume":"35","author":"DD Erdman","year":"1991","unstructured":"Erdman DD, Usher MJ, Tsou C, Caul EO, Gary GW, Kajigaya S, et al. Human parvovirus B19 specific IgG, IgA, and IgM antibodies and DNA in serum specimens from persons with erythema infectiosum. J Med Virol. 1991;35(2):110\u20135.","journal-title":"J Med Virol"},{"issue":"7","key":"1911_CR17","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1093\/cid\/cis1046","volume":"56","author":"Y Crabol","year":"2013","unstructured":"Crabol Y, Terrier B, Rozenberg F, Pestre V, Legendre C, Hermine O, et al. Intravenous immunoglobulin therapy for pure red cell aplasia related to human parvovirus b19 infection: a retrospective study of 10 patients and review of the literature. Clin Infect Dis Off Publ Infect Dis Soc Am. 2013;56(7):968\u201377.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"1","key":"1911_CR18","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1537-2995.2007.01503.x","volume":"48","author":"J Modrof","year":"2008","unstructured":"Modrof J, Berting A, Tille B, Klotz A, Forstner C, Rieger S, et al. Neutralization of human parvovirus B19 by plasma and intravenous immunoglobulins. Transfusion (Paris). 2008;48(1):178\u201386.","journal-title":"Transfusion (Paris)"},{"issue":"4","key":"1911_CR19","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1128\/JCM.24.4.522-526.1986","volume":"24","author":"LJ Anderson","year":"1986","unstructured":"Anderson LJ, Tsou C, Parker RA, Chorba TL, Wulff H, Tattersall P, et al. Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assay. J Clin Microbiol. 1986;24(4):522\u20136.","journal-title":"J Clin Microbiol"},{"issue":"3","key":"1911_CR20","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0928-0197(96)00262-0","volume":"7","author":"IP Jensen","year":"1997","unstructured":"Jensen IP, Vestergaard BF. Assessment of the specificity of a commercial human parvovirus B19 IgM assay. Clin Diagn Virol. 1997;7(3):133\u20137.","journal-title":"Clin Diagn Virol"},{"issue":"9","key":"1911_CR21","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.amjmed.2015.02.017","volume":"128","author":"P Cacoub","year":"2015","unstructured":"Cacoub P, Comarmond C, Domont F, Savey L, Saadoun D. Cryoglobulinemia Vasculitis. Am J Med. 2015;128(9):950\u20135.","journal-title":"Am J Med"},{"issue":"7","key":"1911_CR22","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1086\/651164","volume":"50","author":"L Chiche","year":"2010","unstructured":"Chiche L, Grados A, Harl\u00e9 J-R, Cacoub P. Mixed cryoglobulinemia: a role for parvovirus b19 infection. Clin Infect Dis Off Publ Infect Dis Soc Am. 2010;50(7):1074\u20135.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am."},{"issue":"1","key":"1911_CR23","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jbspin.2016.12.013","volume":"85","author":"PE Lazzerini","year":"2018","unstructured":"Lazzerini PE, Cusi MG, Selvi E, Capecchi M, Moscadelli V, Migliacci N, et al. Non-HCV-related cryoglobulinemic vasculitis and parvovirus-B19 infection. Jt Bone Spine Rev Rhum. 2018;85(1):129\u201330.","journal-title":"Jt Bone Spine Rev Rhum"},{"key":"1911_CR24","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jaut.2015.08.008","volume":"65","author":"B Terrier","year":"2015","unstructured":"Terrier B, Marie I, Lacraz A, Belenotti P, Bonnet F, Chiche L, et al. Non HCV-related infectious cryoglobulinemia vasculitis: results from the French nationwide CryoVas survey and systematic review of the literature. J Autoimmun. 2015;65:74\u201381.","journal-title":"J Autoimmun"},{"issue":"6","key":"1911_CR25","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1002\/cbf.1364","volume":"25","author":"A Pugliese","year":"2007","unstructured":"Pugliese A, Beltramo T, Torre D, Roccatello D. Parvovirus B19 and immune disorders. Cell Biochem Funct. 2007;25(6):639\u201341.","journal-title":"Cell Biochem Funct"},{"issue":"4","key":"1911_CR26","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1136\/ard.2004.024877","volume":"64","author":"J Hermann","year":"2005","unstructured":"Hermann J, Demel U, St\u00fcnzner D, Daghofer E, Tilz G, Graninger W. Clinical interpretation of antineutrophil cytoplasmic antibodies: parvovirus B19 infection as a pitfall. Ann Rheum Dis. 2005;64(4):641\u20133.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"1911_CR27","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.autrev.2006.09.006","volume":"6","author":"P von Landenberg","year":"2007","unstructured":"von Landenberg P, Lehmann HW, Modrow S. Human parvovirus B19 infection and antiphospholipid antibodies. Autoimmun Rev. 2007;6(5):278\u201385.","journal-title":"Autoimmun Rev"},{"issue":"3","key":"1911_CR28","first-page":"840","volume":"6","author":"LA Barnett","year":"1992","unstructured":"Barnett LA, Fujinami RS. Molecular mimicry: a mechanism for autoimmune injury. FASEB J Off Publ Fed Am Soc Exp Biol. 1992;6(3):840\u20134.","journal-title":"FASEB J Off Publ Fed Am Soc Exp Biol"},{"issue":"6","key":"1911_CR29","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1080\/17843286.2015.1111673","volume":"71","author":"E Georges","year":"2016","unstructured":"Georges E, Rihova Z, Cmejla R, Decleire P-Y, Langen C. Parvovirus B19 induced lupus-like syndrome with nephritis. Acta Clin Belg. 2016;71(6):423\u20135.","journal-title":"Acta Clin Belg"},{"issue":"9","key":"1911_CR30","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1093\/infdis\/jiy614","volume":"219","author":"K Puttaraksa","year":"2019","unstructured":"Puttaraksa K, et al. Parvovirus B19V Nonstructural Protein NS1 Induces Double-Stranded Deoxyribonucleic Acid Autoantibodies and End-Organ Damage in Nonautoimmune Mice. J Infect Dis. 2019;219(9):1418\u201329. https:\/\/doi.org\/10.1093\/infdis\/jiy614.","journal-title":"J Infect Dis"},{"issue":"1","key":"1911_CR31","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s10067-007-0691-1","volume":"27","author":"T Sugimoto","year":"2008","unstructured":"Sugimoto T, Tsuda A, Uzu T, Kashiwagi A. Emerging lupus-like manifestations in acute parvovirus B19 infection. Clin Rheumatol. 2008;27(1):119\u201320.","journal-title":"Clin Rheumatol"},{"issue":"6","key":"1911_CR32","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/S0272-6386(00)70055-2","volume":"35","author":"S Tanawattanacharoen","year":"2000","unstructured":"Tanawattanacharoen S, Falk RJ, Jennette JC, Kopp JB. Parvovirus B19 DNA in kidney tissue of patients with focal segmental glomerulosclerosis. Am J Kidney Dis Off J Natl Kidney Found. 2000;35(6):1166\u201374.","journal-title":"Am J Kidney Dis Off J Natl Kidney Found"},{"key":"1911_CR33","doi-asserted-by":"publisher","unstructured":"Prasad B, Onge JS. Parvovirus Leading to Thrombotic Microangiopathy in a Healthy Adult. BMJ Case Rep. 2016;2016. https:\/\/doi.org\/10.1136\/bcr-2015-213492.","DOI":"10.1136\/bcr-2015-213492"},{"issue":"14","key":"1911_CR34","doi-asserted-by":"publisher","first-page":"8102","DOI":"10.1128\/JVI.00649-14","volume":"88","author":"K von Kietzell","year":"2014","unstructured":"von Kietzell K, Pozzuto T, Heilbronn R, Gr\u00f6ssl T, Fechner H, Weger S. Antibody-mediated enhancement of parvovirus B19 uptake into endothelial cells mediated by a receptor for complement factor C1q. J Virol. 2014;88(14):8102\u201315.","journal-title":"J Virol"},{"key":"1911_CR35","doi-asserted-by":"publisher","first-page":"238","DOI":"10.5414\/CN108694","volume":"85","author":"H Marco","year":"2016","unstructured":"Marco H, et al. Postinfectious Glomerulonephritis Secondary to Erythrovirus B19 (Parvovirus B19): Case Report and Review of the Literature. Clin Nephrol. 2016;85:238\u201344. https:\/\/doi.org\/10.5414\/CN108694.","journal-title":"Clin Nephrol"},{"issue":"3","key":"1911_CR36","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1159\/000046086","volume":"89","author":"S Takeda","year":"2001","unstructured":"Takeda S, Takaeda C, Takazakura E, Haratake J. Renal involvement induced by human parvovirus B19 infection. Nephron. 2001;89(3):280\u20135.","journal-title":"Nephron"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-020-01911-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-020-01911-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-020-01911-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T12:35:14Z","timestamp":1723206914000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-020-01911-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,9]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1911"],"URL":"https:\/\/doi.org\/10.1186\/s12882-020-01911-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.11057\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.11057\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.11057\/v2","asserted-by":"object"}]},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,9]]},"assertion":[{"value":"7 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in this study were in accordance with the ethical standards of the institutional research committee (Institut National des Donn\u00e9es de Sant\u00e9) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Written informed consent for the use of samples and clinical data was obtained from all individual participants included in the biocollection (DC-2012-1704, which comprises blood and urine samples as well as kidney biopsies). The institutional review board of AP-HM approved this study, and stated that, according to the French legislation on the protection of personal data, no registration number was needed for this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The 4 case reports mentioned in this manuscript were not published previously. Written informed consent was obtained from each patient for publication of their results.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Pr Olivier Moranne is an Editorial Board Member of BMC Nephrology. None of the other authors have any competing interests to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"260"}}